Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombus.
Lau WY, Wang K, Zhang XP, Li LQ, Wen TF, Chen MS, Jia WD, Xu L, Shi J, Guo WX, Sun JX, Chen ZH, Guo L, Wei XB, Lu CD, Xue J, Zhou LP, Zheng YX, Wang M, Wu MC, Cheng SQ. Lau WY, et al. Among authors: zhou lp. Hepatobiliary Surg Nutr. 2021 Dec;10(6):782-795. doi: 10.21037/hbsn-19-810. Hepatobiliary Surg Nutr. 2021. PMID: 35004945 Free PMC article.
Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world.
Feng JK, Liu ZH, Fu ZG, Chai ZT, Sun JX, Wang K, Cheng YQ, Zhu HF, Xiang YJ, Zhou LP, Shi J, Guo WX, Zhai J, Cheng SQ. Feng JK, et al. Among authors: zhou lp. Front Oncol. 2022 Nov 25;12:954203. doi: 10.3389/fonc.2022.954203. eCollection 2022. Front Oncol. 2022. PMID: 36505818 Free PMC article.
Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study.
Wang K, Liu ZH, Yu HM, Cheng YQ, Xiang YJ, Zhong JY, Ni QZ, Zhou LP, Liang C, Zhou HK, Pan WW, Guo WX, Shi J, Cheng SQ. Wang K, et al. Among authors: zhou lp, zhou hk. Therap Adv Gastroenterol. 2023 Mar 28;16:17562848231160630. doi: 10.1177/17562848231160630. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37007215 Free PMC article.
Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.
Zhu HF, Feng JK, Xiang YJ, Wang K, Zhou LP, Liu ZH, Cheng YQ, Shi J, Guo WX, Cheng SQ. Zhu HF, et al. Among authors: zhou lp. BMC Cancer. 2023 Jun 15;23(1):547. doi: 10.1186/s12885-023-11003-0. BMC Cancer. 2023. PMID: 37322411 Free PMC article.
Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study.
Sun J, Mao F, Liu C, Zhang F, Jiang D, Guo W, Huo L, Zhou L, Lau WY, Shi J, Cheng S. Sun J, et al. Signal Transduct Target Ther. 2023 Sep 27;8(1):368. doi: 10.1038/s41392-023-01604-3. Signal Transduct Target Ther. 2023. PMID: 37752117 Free PMC article. Clinical Trial.
268 results